Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives $22.78 Average PT from Analysts
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned an average rating of “Hold” from the nine ratings firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned an average rating of “Hold” from the nine ratings firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the […]
